91AV

Introduction

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies. Following this is a dedicated Digital Day delivered through our online event platform

Useful links

Speakers

• Luke Devey Vice President, Translational Sciences, Immunology
  Janssen, United Kingdom
• Jeffrey Wallin Senior Director, Biomarker Sciences
  Gilead, United Kingdom
• Ewa Carrier Executive Director, Clinical Development
  Fibrogen, United Kingdom
• Jadwiga Bienkowska Sr. Director, Computational Biology ORD
  Pfizer, United Kingdom
• Kevin Gergich Executive Director, Oncology Clinical Operations
  MSD, United Kingdom

---

Venue

TBC

TBC, TBC, San Diego, TBC, United States

Organised by

Oxford Global

Contact information

Bronwyn Westmore
Oxford Global
Contact us by email

---